药用甘油基产品市场规模、份额及成长分析（依药物类型、剂型、应用、最终用户及地区划分）－2026-2033年产业预测

预计到 2024 年，全球药用甘油产品市场规模将达到 2.871 亿美元，到 2025 年将增长至 3.2327 亿美元，到 2033 年将增长至 8.3537 亿美元，在预测期（2026-2033 年）内复合增长率为 12.6%。

全球药用甘油产品市场正经历显着成长，这主要得益于甘油作为添加剂和活性成分的多样化作用。甘油因其保湿、润滑和甜味功效而备受认可，在包括外用皮肤治疗剂、眼用溶液、止咳药和栓剂在内的多种药物製剂中发挥着重要作用。慢性皮肤病和眼科疾病（包括青光眼）的日益普遍，进一步推动了甘油作为眼压降低剂的需求。对高纯度药用级甘油的需求趋势，凸显了消费者和监管机构对安全、洁净标示产品的关注。儘管竞争激烈，杜邦、黑田国际和陶氏化学等主要企业仍在扩大产能，以满足不断增长的市场需求。

推动全球药用甘油产品市场发展的因素

全球药用甘油产品市场的主要驱动力是市场对药用级原料日益增长的需求。甘油是一种无毒的保湿添加剂，能够增强多种药品（包括止咳糖浆、外用乳膏和眼药水）的疗效。个人护理产业的蓬勃发展进一步推动了这一需求的成长，消费者越来越倾向于选择含有天然植物成分的产品，例如保湿霜和消毒剂。因此，这些应用领域对高纯度甘油的需求至关重要，凸显了甘油在製药和个人护理行业中的重要角色。

限制全球药用甘油产品市场的因素

导引甘油类药物市场发展的一大挑战是关键原物料价格波动。这些原料主要来自棕榈油、大豆油和芥花籽油等植物油，也用于生质柴油生产。价格波动造成了市场环境的不确定性，使生产者难以准确估算成本。这种不确定性可能导致生产商不愿签订长期合约，并推迟投资决策，可能损害市场稳定性和行业成长潜力。

甘油类药物的全球市场趋势

全球甘油基医药产品市场正经历一场由人工智慧 (AI) 和机器学习技术融合所驱动的变革。这些先进的解决方案正在革新生产方式，并提升整个供应链的品管。透过优化批量生产和实现即时过程控制，人工智慧和机器学习能够帮助製造商提高效率并降低营运成本。此外，预测分析有助于预测维修需求，最终打造更具韧性和反应能力的生产环境。随着这些技术的不断发展，它们有望重塑行业标准，并催生出更多创新且永续的甘油基产品。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争格局概述

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估
• 技术评估
• 监管环境

全球药用甘油类产品市场规模（按药物类型和复合年增长率划分）（2026-2033 年）

• 皮肤科
• 眼科
• 止咳药
• 甘油直肠剂
• 其他的

全球药用甘油基产品市场规模（按配方和复合年增长率划分）（2026-2033 年）

• 糖浆和酏剂
• 外用液
• 栓剂
• 眼药水和口服液
• 药物传输添加剂

全球药用甘油基产品市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 配方中的添加剂
• 保湿剂和润湿剂的应用
• 药用溶剂/甜味剂
• 药物稳定化和药物递送
• 特殊治疗应用

全球药用甘油基产品市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 製药公司
• 合约配药公司
• 医院和临床药房
• 研究和学术机构
• 专业製药製造商

全球药用甘油基产品市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• BASF SE
• Dow Inc.
• Glycerin Products LLC
• Cargill, Incorporated
• Wilmar International Limited
• Kraton Corporation
• Emery Oleochemicals
• Vantage Specialty Chemicals
• Croda International plc
• DuPont de Nemours, Inc.
• Capsugel（Lonza）
• ABBVie Inc.
• Johnson & Johnson
• Abbott Laboratories
• Bausch Health Companies Inc.
• Takeda Pharmaceutical Company
• The Dow Chemical Company
• IOI Oleochemical（Oleon）
• KLK OLEO
• Archer Daniels Midland Company

结论与建议

Global Pharmaceutical Glycerin Based Products Market size was valued at USD 287.1 million in 2024 and is poised to grow from USD 323.27 million in 2025 to USD 835.37 million by 2033, growing at a CAGR of 12.6% during the forecast period (2026-2033).

The market for global pharmaceutical glycerin-based products is experiencing significant growth driven by glycerin's diverse roles as an excipient and active ingredient. Recognized for its effectiveness as a humectant, lubricant, and sweetening agent, glycerin plays a vital role in various pharmaceutical formulations, such as topical skin treatments, ocular solutions, cough medications, and suppositories. The rising prevalence of chronic skin conditions and eye disorders, including glaucoma, further propels demand for glycerin's use in reducing intraocular pressure. A trend towards sourcing high-purity, pharmaceutical-grade glycerin underscores a consumer and regulatory focus on safe, clean-label products. While competition is robust, major players like DuPont, Croda International, and The Dow Chemical Company are enhancing production capacity to cater to the increasing market demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerin Based Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerin Based Products Market Segments Analysis

Global Pharmaceutical Glycerin Based Products Market is segmented by Drug Type, Formulation, Application Area, End User and region. Based on Drug Type, the market is segmented into Dermatological, Ophthalmic, Cough Remedies, Glycerin Rectal and Others. Based on Formulation, the market is segmented into Syrups & Elixirs, Topical Solutions, Suppositories, Eye / Oral Solutions and Excipients for Drug Delivery. Based on Application Area, the market is segmented into Excipients in Formulation, Moisturizing & Humectant Uses, Solvent / Sweetener in Medicines, Drug Stabilization & Delivery and Specialty Therapeutic Uses. Based on End User, the market is segmented into Pharmaceutical Manufacturers, Contract Formulators, Hospitals & Clinical Pharmacies, Research & Academic Institutions and Specialty Drug Producers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerin Based Products Market

The global pharmaceutical glycerin-based products market is primarily driven by the increasing demand for pharmaceutical-grade ingredients. Glycerin serves as a non-toxic, moisturizing excipient that enhances the efficacy of various medications, including cough syrups, topical creams, and eye solutions. This growing demand is further bolstered by the personal care sector, where consumers are increasingly inclined to choose products featuring natural, plant-derived ingredients, including moisturizers and germicidal sanitizers. Consequently, the need for high-purity glycerin becomes essential in these applications, highlighting its pivotal role in both the pharmaceutical and personal care industries.

Restraints in the Global Pharmaceutical Glycerin Based Products Market

A significant challenge hindering the advancement of the pharmaceutical glycerin-based products market is the variability in prices of their key feedstock, primarily derived from vegetable oils such as palm, soybean, and canola oils, which are also utilized in biodiesel production. These price fluctuations create an environment of unpredictability, making it difficult for manufacturers to estimate costs accurately. This uncertainty may lead to hesitation in committing to long-term contracts and can result in delayed investment decisions, ultimately diminishing market stability and growth potential within the industry.

Market Trends of the Global Pharmaceutical Glycerin Based Products Market

The Global Pharmaceutical Glycerin Based Products market is witnessing a transformative trend driven by the integration of artificial intelligence and machine learning technologies. These advanced solutions are revolutionizing production methodologies and enhancing quality management throughout the supply chain. By optimizing batch production and facilitating real-time process control, AI and machine learning enable manufacturers to improve efficiency and reduce operational costs. Furthermore, predictive analytics aid in forecasting maintenance requirements, ultimately fostering a more resilient and responsive production environment. As these technologies continue to evolve, they are expected to reshape industry standards, leading to more innovative and sustainable glycerin-based product offerings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment
• Technology Assessment
• Regulatory Landscape

Global Pharmaceutical Glycerin Based Products Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Dermatological
• Ophthalmic
• Cough Remedies
• Glycerin Rectal
• Others

Global Pharmaceutical Glycerin Based Products Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Syrups & Elixirs
• Topical Solutions
• Suppositories
• Eye / Oral Solutions
• Excipients for Drug Delivery

Global Pharmaceutical Glycerin Based Products Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Excipients in Formulation
• Moisturizing & Humectant Uses
• Solvent / Sweetener in Medicines
• Drug Stabilization & Delivery
• Specialty Therapeutic Uses

Global Pharmaceutical Glycerin Based Products Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Manufacturers
• Contract Formulators
• Hospitals & Clinical Pharmacies
• Research & Academic Institutions
• Specialty Drug Producers

Global Pharmaceutical Glycerin Based Products Market Size & CAGR (2026-2033)

• North America (Drug Type, Formulation, Application Area, End User)
  • US
  • Canada
• Europe (Drug Type, Formulation, Application Area, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Formulation, Application Area, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Formulation, Application Area, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Formulation, Application Area, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycerin Products LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilmar International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kraton Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emery Oleochemicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vantage Specialty Chemicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont de Nemours, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capsugel (Lonza)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABBVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Dow Chemical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOI Oleochemical (Oleon)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLK OLEO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations